Single-shot bevacizumab for cerebral radiation injury

BACKGROUND: Cerebral radiation injury, including subacute radiation reactions and later stage radiation necrosis, is a severe side effect of brain tumor radiotherapy. A protocol of four infusions of the monoclonal antibody bevacizumab has been shown to be a highly effective treatment. However, bevac...

Descripción completa

Detalles Bibliográficos
Autores principales: Voss, Martin, Wenger, Katharina J., Fokas, Emmanouil, Forster, Marie-Thérèse, Steinbach, Joachim P., Ronellenfitsch, Michael W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888179/
https://www.ncbi.nlm.nih.gov/pubmed/33596839
http://dx.doi.org/10.1186/s12883-021-02103-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888179/
https://www.ncbi.nlm.nih.gov/pubmed/33596839
http://dx.doi.org/10.1186/s12883-021-02103-0

Ejemplares similares